Assisted Reproductive Technology Market - Global Industry Insights, Trends and Forecast 2017-2025 Assisted Reproductive Technology Market: Introduction Assisted reproductive technology is the technology to achieve conception by surgically removing eggs from a female to combine them with sperms in a laboratory, under specialized conditions, further placing them in ovaries of the female or in ovaries of surrogate mother. The assisted reproductive technology market is gaining traction, due to rising infertility issues among women, coupled with its efficacy in preserving the genetic connection of child with the biological parents. Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/235 Market Dynamics: The assisted reproductive technology market is anticipated to grow during the forecast period due to increased infertility incidents, owing to reasons like increased alcohol consumption, smoking, obesity, and stress. According to the National Institutes of Mental Health, approximately 1 out of 75 people experience panic disorder and mental issues. The growing acceptance of this technology by various population, coupled with advancements made in the sector in recent years, is further expected to boost the global assisted reproductive technology market. However, social stigma attached with these technologies, coupled with high treatment costs can restrain the growth of assisted reproductive technology market in developing countries. For instance, the cost of IVF in India normally ranges between $1,400 to $5,500 per treatment cycle. Technology Insight: Among various technologies available, in-vitro fertilization-embryo transfer method is expected to hold a major share in the revenue generation, due to its higher success rates, ease of procedure, reimbursement policies and availability of a number of IVF centers and fertility clinics. According to CDC’s (Centers for Disease Control and Prevention) Fertility Clinic Success Rates report in 2016, total 263,577 ART cycles were performed at 463 reporting clinics in the U.S. (in 2016), out of which 65,996 resulted in live births (deliveries of one or more living infants) and 76,930 resulted in live born infants. Procedure Insight: In the procedure segment, fresh non-donor segment is expected to grow significantly due to their efficacy to retain the genetic connection between the child and biological parents. According to Center for Disease Control and Prevention (CDC), fresh non-donor procedure was the highest used procedure in ART in 2015, which accounted for 39.3% of the total performed assisted reproductive technology cycles. Frozen non-donor segment was the second most used procedure, accounted for 30.1% of the total ART cycles. End-Use Insights: Hospitals and fertility clinics are the widely segmented end-users of assisted reproductive technology market. Among these two, specialized fertility clinics are expected to be holding the major revenue share in the global assisted reproductive technology market, due to global rise in number of fertility clinics. Presence of fertility clinics like GATJC Fertlity Center, IVF Spain and Embryolab ensures the future growth of fertility clinics in the treatment of assisted reproductive technology market. Regional Insight: North America and Europe are expected to hold major revenue share in the global assisted reproductive technology market, owing to the presence of advanced medical infrastructure in this region. According to CDC, approximately 1.5 million IVF cycles is performed per year globally, out of which 55% of the reported IVF cycles are performed in Europe. The increasing awareness of consumers, along with high disposable incomes of people in these regions will further drive the regional markets. Asia Pacific is expected to show significant market growth in the forecast period, due to increased social acceptance of ART in the region, coupled with increase in infertility cases among countries like India and South Korea and Japan. According to Open Government Data Platform (OGD), total fertility rate (TFR) declined in India by 22.73% from 2.7 in 2005-06 to 2.2 in 2015-16. Competitive Landscape Key market players operating in assisted reproductive technology market include Nidacon International AB, Merck, Parallabs, Laboratoire CCD, CooperSurgical, Inc., Esco Micro Private Limited, Hamilton Thorne, Inc., Cosmos Biomedical Limited, Bloom IVF Center, Ferring Pharmaceuticals, Irvine Scientific, and Nikon Corporation. On 28 January, 2018, UAE healthcare giant NMC Health completely acquired Fakih IVF to expand their business. In February 2017, Instituto Valenciano de Infertilidad (IVI), announced their entrance in the USA by signing an agreement with Reproductive Medicine Associates of New Jersey (RMANJ). For more information about this report @ https://www.insightsandreports.com/industry-reports/assisted-reproductive-technology-market About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us: Mr. Saby Insights And Reports 2201 Cooperative Way #600, Herndon, VA 20171, USA. Tel: +1 703 574 4447 Email: [email protected]